Park Avenue Securities LLC Purchases 380 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Park Avenue Securities LLC boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 4.9% in the 4th quarter, Holdings Channel reports. The firm owned 8,087 shares of the medical device company’s stock after buying an additional 380 shares during the quarter. Park Avenue Securities LLC’s holdings in Cooper Companies were worth $743,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp raised its stake in shares of Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after acquiring an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after acquiring an additional 48,559 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after acquiring an additional 194,118 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

NASDAQ COO opened at $95.35 on Wednesday. The firm’s fifty day simple moving average is $96.21 and its two-hundred day simple moving average is $99.20. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The firm has a market capitalization of $19.03 billion, a P/E ratio of 48.90, a P/E/G ratio of 2.36 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the company earned $0.87 earnings per share. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. Analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.